EUVIMEDEUVIMED entdecken
Crossref

Using Metal–Organic Framework Nanoparticles for Targeted Codelivery of Bortezomib and Iron Ions to Mitochondrial TOM20 to Induce Ferroptosis for Colorectal Cancer Treatment

Yao-Hua Lu, Fan Leng, Si-Yuan Chen, Chen-Yu Wang, Chang-Long Gou, Ting-Ting Yu, Liu-Gen Li, Hai-Tao Li, Min Yan, Qiufang Zhang, Tong-Fei Li iD, Jian Yin iD und 2 weitere

Molecular Pharmaceutics · 04.08.2025 · 22 (8) · 4865-4878

DOI: 10.1021/acs.molpharmaceut.5c00489 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 17.07.2025. Verfasst von Yao-Hua Lu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Shiyan Key Laboratory of Natural Medicine Nanoformulation Research, Hubei Key Laboratory of Embryonic Stem Cell Research, School of Basic Medical Sci…. Hauptthemen laut MEDLINE: Ferroptosis, Iron, Bortezomib, Metal-Organic Frameworks. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National College Students Innovation and Entrepreneurship Training Program, Natural Science Foundation of Hubei Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted promotion of iron ion accumulation and inhibition of outer membrane protein function in mitochondria contribute to ferroptosis, thereby boosting anticolorectal cancer (CRC) efficacy. Based on our previous study, the anticancer agent bortezomib (BTZ) was loaded in an iron-derived metal-organic framework (MOF), which was further modified by rhodamine B (RhB), yielding BTZ@RhB-MOF for targeted CRC treatment. Physicochemical characterization results indicated successful preparation of BTZ@RhB-MOF, which had the framework structure and nanosize properties with BTZ and iron ion release under acidic conditions. Further measurements indicated that BTZ@RhB-MOF could be distributed more effectively in tumor tissues, owing to its targeted characteristics. BTZ@RhB-MOF was mainly localized at the mitochondrial outer membrane, where it bound to TOM20 and subsequently destroyed the mitochondria of CRC cells. Then, BTZ@RhB-MOF released the iron ions it was carrying, increasing the concentration of intracellular iron ions and inducing vigorous ferroptosis. Finally, in vitro and in vivo experiments demonstrated that BTZ@RhB-MOF could suppress CRC cells and tumor grafts in CRC cell-bearing mice with favorable safety. Thus, the targeted codelivery of BTZ and iron ions using MOF to the mitochondria of CRC cells was achieved. Therefore, BTZ@RhB-MOF can effectively induce ferroptosis by suppressing TOM20 and increasing iron ion concentrations after the agents are unloaded, offering a potentially targeted strategy for CRC chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisIronBortezomibMetal-Organic FrameworksColorectal NeoplasmsNanoparticlesAnimalsHumansMiceMitochondriaCell Line, TumorAntineoplastic AgentsXenograft Model Antitumor AssaysMice, Inbred BALB CRhodaminesMice, NudeDrug Delivery Systems

Stichwörter der Autor:innen

TOM20bortezomibcolorectal cancerferroptosismetal−organic framework

Substanzen

IronBortezomibMetal-Organic FrameworksAntineoplastic AgentsRhodamines

Autor:innen und Institutionen

  • Shiyan Key Laboratory of Natural Medicine Nanoformulation Research, Hubei Key Laboratory of Embryonic Stem Cell Research, School of Basic Medical Sciences, Hubei University of Medicine, Renmin road No. 30, Shiyan 442000…
  • Department of General Surgery, Taihe Hospital, Hubei University of Medicine, Renmin south road No. 32, Shiyan 442000, Hubei, China.
  • Department of Ultrasound Medicine, Taihe Hospital, Hubei University of Medicine, Renmin south road No. 32, Shiyan 442000, Hubei, China.
  • Department of Pathology, Renmin Hospital of Shiyan, Hubei University of Medicine, Shiyan 442000, Hubei, China.
  • School of Biotechnology, Key Laboratory of Carbohydrate Chemistry and Biotechnology of Ministry of Education, School of Life Sciences and Health Engineering, Innovation Center for Vaccine Engineering, Jiangnan Universit…

ORCID-Profile: Tong-Fei Li, Jian Yin, Jun Hu

Förderung

  • National College Students Innovation and Entrepreneurship Training Program
  • Natural Science Foundation of Hubei Province
  • National Natural Science Foundation of China
  • Natural Science Foundation of Hubei Provincial Department of Education
  • Project in Administration Bureau of Traditional Chinese Medicine of Hubei Province
  • Cultivating Project for Young Scholar, Hubei University of Medicine
  • Excellent Young and Middle-aged Scientific and Technological Innovation Team of Universities of Hubei Province
  • Innovative Research Program for Graduates of Hubei University of Medicine

Zitieren

APA

Lu, Y. H., Leng, F., Chen, S. Y., Wang, C. Y., Gou, C. L., Yu, T. T., Li, L. G., Li, H. T., Yan, M., Zhang, Q., Li, T. F., Yin, J., Hui, Y. J., & Hu, J. (2025). Using Metal–Organic Framework Nanoparticles for Targeted Codelivery of Bortezomib and Iron Ions to Mitochondrial TOM20 to Induce Ferroptosis for Colorectal Cancer Treatment. Molecular Pharmaceutics, 22(8), 4865-4878. https://doi.org/10.1021/acs.molpharmaceut.5c00489

Vancouver

Lu YH, Leng F, Chen SY, Wang CY, Gou CL, Yu TT, et al. Using Metal–Organic Framework Nanoparticles for Targeted Codelivery of Bortezomib and Iron Ions to Mitochondrial TOM20 to Induce Ferroptosis for Colorectal Cancer Treatment. Molecular Pharmaceutics. 2025;22(8):4865-4878. doi:10.1021/acs.molpharmaceut.5c00489

BibTeX
@article{Lu2025,
  author = {Lu, Yao-Hua and Leng, Fan and Chen, Si-Yuan and Wang, Chen-Yu and Gou, Chang-Long and Yu, Ting-Ting and Li, Liu-Gen and Li, Hai-Tao and Yan, Min and Zhang, Qiufang and Li, Tong-Fei and Yin, Jian and Hui, Yuan-Jian and Hu, Jun},
  title = {Using Metal–Organic Framework Nanoparticles for Targeted Codelivery of Bortezomib and Iron Ions to Mitochondrial TOM20 to Induce Ferroptosis for Colorectal Cancer Treatment},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  volume = {22},
  number = {8},
  pages = {4865--4878},
  doi = {10.1021/acs.molpharmaceut.5c00489}
}
Kostenlos starten →